NewAmsterdam Pharma Reports Inducement Grants

Biotech company grants share options to four new hires under Nasdaq listing rule.

Published on Feb. 8, 2026

Got story updates? Submit your updates here. ›

NewAmsterdam Pharma, a late-stage biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease, announced that its Compensation Committee approved the grant of inducement share options covering an aggregate of 217,000 ordinary shares to four new non-executive hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the company's 2024 Inducement Plan and in accordance with Nasdaq Listing Rule 5635(c)(4).

Why it matters

The inducement grants are a common practice for public companies to attract top talent, especially in the competitive biotech industry. These grants help align the interests of new hires with those of existing shareholders as the options only have value if the company's stock price increases over time.

The details

The share options have an exercise price per share of $31.57, which represents the closing market price on the Nasdaq Stock Market on the grant date of February 2, 2026. The shares subject to the options will vest over four years, with 25% vesting on the one-year anniversary of the applicable vesting commencement date and the balance vesting in 36 equal monthly installments thereafter, subject to each employee's continued service.

  • The Compensation Committee of NewAmsterdam's Board of Directors approved the inducement grants on February 6, 2026.
  • The share options were granted on February 2, 2026, the closing market price date used for the exercise price.

The players

NewAmsterdam Pharma Company N.V.

A late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease.

2024 Inducement Plan

NewAmsterdam's equity incentive plan used to grant inducement share options to new hires.

Got photos? Submit your photos here. ›

The takeaway

The inducement grants demonstrate NewAmsterdam's commitment to attracting top talent as it advances its pipeline of cardiovascular disease treatments. These types of equity awards are a common practice for public biotech companies to incentivize and retain key personnel.